Catabolic outcome from non-gastrointestinal malignancy-related malabsorption leading to malnutrition and weight loss

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 8, Issue 4, 2005, Pages 419-427

  Suzuki, Sususmu ^a   Goncalves, Carolina G ^a   Meguid, Michael M ^a,b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b University Hospital   (United States)

Author keywords

Cancer; Catabolism; Gut function

Indexed keywords

CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; GASTROINTESTINAL HORMONE; INTERLEUKIN 1; NEUROPEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

CANCER MORTALITY; CANCER PATIENT; CATABOLISM; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GASTROINTESTINAL MOTILITY; HUMAN; INTESTINE MUCOSA; MALABSORPTION; MALIGNANT NEOPLASTIC DISEASE; MALNUTRITION; REVIEW; SMALL INTESTINE ABSORPTION; SMALL INTESTINE DISEASE; STOMACH EMPTYING; VAGUS NERVE; WEIGHT REDUCTION;

EID: 20844450373     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mco.0000172583.25009.ab     Document Type: Review

References (85)

1. Laviano A, Meguid MM, Inui A, et al. Therapy insight: cancer anorexia - cachexia syndrome - when all you can eat is yourself. Nat Clin Pract Oncol 2005; 2:1-8. A comprehensive review of the physiological and clinical implications of cancer anorexia, and also a comprehensive review of the new therapeutic approaches to cancer anorexia.
2. Mantovani G, Maccio A, Massa E, Madeddu C. Managing cancer-related anorexia/cachexia. Drugs 2001; 61:499-514.
3. Inui A. Cancer anorexia - cachexia syndrome: are neuropeptides the key? Cancer Res 1999; 59:4493-4501.
4. Warren S. The immediate cause of death in cancer. Am J Med Sci 1932; 184:610-615.
5. Lanzotti VJ, Thomas DR, Boyle LE, et al. Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria. Cancer 1977; 39:303-313.
6. Staal-van den Brekel AJ, Schols AM, ten Velde GP, et al. Analysis of the energy balance in lung cancer patients. Cancer Res 1994; 54:6430-6433.
7. Wigmore SJ, Plester CE, Ross JA, Fearon KC. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 1997; 84:196-197.
8. Inui A. Cancer anorexia - cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52:72-91.
9. Prima V, Tennant M, Gorbatyuk OS, et al. Differential modulation of energy balance by leptin, ciliary neurotrophic factor, and leukemia inhibitory factor gene delivery: microarray deoxyribonucleic acid-chip analysis of gene expression. Endocrinology 2004; 145:2035-2045.
10. Inui A. Feeding and body-weight regulation by hypothalamic neuropeptides - mediation of the actions of leptin. Trends Neurosci 1999; 22:62-67.
11. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997; 315:1219-1222.
12. Veerabagu MP, Meguid MM, Oler A, Levine RA. Intravenous nucleosides and a nucleotide promote healing of small bowel ulcers in experimental enterocolitis. Dig Dis Sci 1996; 41:1452-1457.
13. Dymock IW, MacKay N, Miller V, et al. Small intestinal function in neoplastic disease. Br J Cancer 1967; 21:505-511.
14. Parrilli G, Iaffaioli RV, Martorano M, et al. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res 1989; 49:3689-3691.
15. Coimbra CR, Plourde V. Abdominal surgery-induced inhibition of gastric emptying is mediated in part by interleukin-1 beta. Am J Physiol 1996; 270:R556-R560.
16. Hardin J, Kroeker K, Chung B, Gall DG. Effect of proinflammatory interleukins on jejunal nutrient transport. Gut 2000; 47:184-191.
17. Wise BE, Schwartz MW, Cummings DE. Melanocortin signaling and anorexia in chronic disease states. Ann NY Acad Sci 2003; 994:275-281.
18. Emch GS, Hermann GE, Rogers RC. TNF-alpha activates solitary nucleus neurons responsive to gastric distension. Am J Physiol Gastrointest Liver Physiol 2000; 279:G582-G586.
19. Cohen MA, Ellis SM, Le Roux CW, et al. Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab 2003; 88:4696-4701.
20. Asakawa A, Inui A, Yuzuriha H, et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003; 124:1325-1336.
21. Tseng WW, Liu CD, Peptide YY, and cancer: current findings and potential clinical applications. Peptides 2002; 23:389-395.
22. Niijima A, Meguid MM. Influence of systemic arginine-lysine on immune organ function: an electrophysiological study. Brain Res Bull 1998; 45:437-441.
23. Nelson KA, Walsh D, Sheehan FA. The cancer anorexia-cachexia syndrome. J Clin Oncol 1994; 12:213-225.
24. Hunt JN. A possible relation between the regulation of gastric emptying and food intake. Am J Physiol 1980; 239:G1-G4.
25. Bruera E, Catz Z, Hooper R, et al. Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J Pain Symptom Manage 1987; 2:19-21.
26. Bruera E, MacDonald N, Brenneis C, et al. Metoclopramide infusion with a disposable portable pump. Ann Intern Med 1986; 104:896.
27. Shivshanker K, Bennett RW Jr, Haynie TP. Tumor-associated gastroparesis: correction with metoclopramide. Am J Surg 1983; 145:221-225.
28. Meguid M, Landel AM, Lo CC, Rivera D. Effect of tumor and tumor removal on DNA, RNA, protein tissue content and survival of methylcholanthrene sarcoma-bearing rat. Surg Res Commun 1987; 1:261-271.
29. Landel AM, Lo CC, Meguid MM, Rivera D. Effect of methylcholanthrene- induced sarcoma and its removal on rat plasma and intracellular free amino acid content. Surg Res Commun 1987; 1:273-287.
30. Wingate D. The eupeptide system: a general theory of gastrointestinal hormones. Lancet 1976; 6:529-532.
31. Mroz CT, Kelly KA. The role of the extrinsic antral nerves in the regulation of gastric emptying. Surg Gynecol Obstet 1977; 145:369-377.
32. Fujimiya M, Inui A. Peptidergic regulation of gastrointestinal motility in rodents. Peptides 2000; 21:1565-1582.
33. Daun JM, McCarthy DO. The role of cholecystokinin in interleukin-1- induced anorexia. Physiol Behav 1993; 54:237-241.
34. Giner M, Laviano A, Meguid MM, Gleason JR. In 1995 a correlation between malnutrition and poor outcome in critically ill patients still exists. Nutrition 1996; 12:23-29.
35. Creamer B. Malignancy and the small-intestinal mucosa. BMJ 1964; 5422:1435-1436.
36. Somayaji BN, Nelson RS, McGregor RF. Small intestinal function in malignant neoplasia. Cancer 1972; 29:1215-1222.
37. Klipstein FA, Smarth G. Intestinal structure and function in neoplastic disease. Am J Dig Dis 1969; 14:887-899.
38. Rubin H. Cancer cachexia: its correlations and causes. Proc Natl Acad Sci U S A 2003; 100:5384-5389.
39. Inui A. Cytokines and sickness behavior: implications from knockout animal models. Trends Immunol 2001; 22:469-473.
40. Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16:1009-1012.
41. Meguid MM, Ramos EJ, Laviano A, et al. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides 2004; 25:261-266. An original paper describing the increased serotonin and the decreased dopamine and neuropeptide Y in the paraventricular nucleus at the onset of cancer anorexia.
42. Plata-Salaman CR. Anorexia during acute and chronic disease. Nutrition 1996; 12:69-78.
43. Sonti G, Ilyin SE, Plata-Salaman CR. Neuropeptide Y blocks and reverses interleukin-1 beta-induced anorexia in rats. Peptides 1996; 17:517-520.
44. Opara EI, Laviano A, Meguid MM, Yang ZJ. Correlation between food intake and CSF IL-1 alpha in anorectic tumor bearing rats. Neuroreport 1995; 6:750-752.
45. Laviano A, Gleason JR, Meguid MM, et al. Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumor-bearing rats. J Invest Med 2000; 48:40-48.
46. Torelli GF, Meguid MM, Moldawer LL, et al. Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats. Am J Physiol 1999; 277:R850-R855.
47. Turrin NP, Ilyin SE, Gayle DA, et al. Interleukin-1 beta system in anorectic catabolic tumor-bearing rats. Curr Opin Clin Nutr Metab Care 2004; 4:419-426. An original paper describing the upregulation of inflammatory cytokines in specific brain regions and their metabolism in the liver at the onset of cancer anorexia.
48. Strassmann G, Masui Y, Chizzonite R, Fong M. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. J Immunol 1993; 150:2341-2345.
49. Laviano A, Renvyle T, Meguid MM, et al. Relationship between interleukin-1 and cancer anorexia. Nutrition 1995; 11:680-683.
50. Muscaritoli M, Meguid MM, Beverly JL, et al. Mechanism of early tumor anorexia. J Surg Res 1996; 60:389-397.
51. Meguid MM, Sato T, Torelli GF, et al. An analysis of temporal changes in meal number and meal size at onset of anorexia in male tumor-bearing rats. Nutrition 2000; 16:305-306.
52. Yang ZJ, Koseki M, Meguid MM, et al. Synergistic effect of rhTNF-α and rhIL-1α in inducing anorexia in rats. Am J Physiol 1994; 267:1056-1064.
53. Tisdale MJ. Biology of cachexia. J Natl Cancer Inst 1997; 89:1763-1773.
54. Yang ZJ, Blaha V, Meguid MM, et al. Interleukin-1α injection into ventromedial hypothalamic nucleus of normal rats depresses food intake and increases release of dopamine and serotonin. Pharmacol Biochem Behav 1999; 62:61-65.
55. Debonis D, Meguid MM, Laviano A, et al. Temporal changes in meal number and meal size relationship in response to rHu IL-1α. Neuroreport 1995; 6:1752-1756.
56. Turrin NP, Gayle D, Ilyin SE, et al. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull 2001; 54:443-453.
57. Robert A, Olafsson AS, Lancaster C, Zhang WR. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci 1991; 48:123-134.
58. McCarthy DO, Daun JM. The role of prostaglandins in interleukin-1 induced gastroparesis. Physiol Behav 1992; 52:351-353.
59. Suto G, Kiraly A, Tache Y. Interleukin 1 beta inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology 1994; 106:1568-1575.
60. Suto G, Kiraly A, Plourde V, Tache Y. Intravenous interleukin-1-beta- induced inhibition of gastric emptying: involvement of central corticotrophin-releasing factor and prostaglandin pathways in rats. Digestion 1996; 57:135-140.
61. Tache Y, Monnikes H, Bonaz B, Rivier J. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann NY Acad Sci 1993; 697:233-243.
62. Daun JM, McCarthy DO. The role of cholecystokinin in interleukin-1- induced anorexia. Physiol Behav 1993; 54:237-241.
63. Kreydiyyeh SI, Haddad JJ, Garabedian BS. Interleukin-1 beta inhibits the intestinal transport of [14C] 3-O-methylglucose in the rat. Life Sci 1998; 63:1913-1919.
64. Cerami A, Tracey KJ, Lowry SF, Beutler B. Cachectin: a pluripotent hormone released during the host response to invasion. Recent Prog Horm Res 1987; 43:99-112.
65. Lonnroth C, Moldawer LL, Gelin J, et al. Tumor necrosis factor-alpha and interleukin-1 alpha production in cachectic, tumor-bearing mice. Int J Cancer 1990; 46:889-896.
66. Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993; 47:169-176.
67. Katafuchi T, Motomura K, Baba S, et al. Differential effects of tumor necrosis factor-α and -β on rat ventromedial hypothalamic neurons in vitro. Am J Physiol 1997; 272:1966-1971.
68. Arbos J, Lopez-Soriano FJ, Carbo N, Argiles JM. Effects of tumour necrosis factor-alpha (cachectin) on glucose metabolism in the rat. Intestinal absorption and isolated enterocyte metabolism. Mol Cell Biochem 1992; 112: 53-59.
69. Hermann GE, Tovar CA, Rogers RC. Induction of endogenous tumor necrosis factor-alpha: suppression of centrally stimulated gastric motility. Am J Physiol 1999; 276:R59-R68.
70. Pendleton RG, Bendesky RJ, Schaffer L, et al. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364, 718, a specific cholecystokinin receptor antagonist. J Pharmacol Exp Ther 1987; 241:110-116.
71. Ljung T, Hellstrom PM. Vasoactive intestinal peptide suppresses migrating myoelectric complex of rat small intestine independent of nitric oxide. Acta Physiol Scand 1999; 165:225-231.
72. Forster ER, Green T, Elliot M, et al. Gastric emptying in rats: role of afferent neurons and cholecystokinin. Am J Physiol 1990; 258:G526-G552.
73. Raybould HE. Capsaicin-sensitive vagal afferents and CCK in inhibition of gastric motor function induced by intestinal nutrients. Peptides 1991; 12:1279-1283.
74. Zarbin MA, Wamsley JK, Innis RB, Kuhar MJ. Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve. Life Sci 1981; 29:697-705.
75. Blackshaw LA, Grundy D. Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre. J Autonom Nerv Syst 1990; 31:191-201.
76. Bucinskaite V, Kurosawa M, Miyasaka K, et al. Interleukin-1 beta sensitizes the response of the gastric vagal afferent to cholecystokinin in rat. Neurosci Lett 1997; 229:33-36.
77. Smith GP, Jerome C, Cushin BJ, et al. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981; 213:1036-1037.
78. Raybould HE, Lloyd KC. Integration of postprandial function in the proximal gastrointestinal tract. Role of CCK and sensory pathways. Ann NY Acad Sci 1994; 713:143-156.
79. Smagin GN, Dunn AJ. The role of CRF receptor subtypes in stress-induced behavioural responses. Eur J Pharmacol 2000; 405:199-206.
80. McCarthy HD, McKibbin PE, Perkins AV, Linton EA, Williams G. Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. Am J Physiol 1993; 264:E638-E643.
81. Tache Y, Garrick T, Raybould H. Central nervous system action of peptides to influence gastrointestinal motor function. Gastroenterology 1990; 98:517-528.
82. Martinez V, Rivier J, Wang L, Tache Y. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF and stress-related alterations of gastric and colonic motor function. J Pharmacol Exp Ther 1997; 280:754-760.
83. Moldawer LL, Rogy MA, Lowry SF. The role of cytokines in cancer cachexia. J Parenter Entera Nutr 1992; 16:43-49.
84. Noguchi Y, Yoshikawa T, Matsumoto A, et al. Are cytokines possible mediators of cancer cachexia? Surg Today 1996; 26:467-475.
85. Matthys P, Billiau A. Cytokines and cachexia. Nutrition 1997; 13:763-770.